Quote:
Originally Posted by Harry Z
This being true and all MS drug trials basing their results on the number of lesions they see on MRIs, what does this say about the accuracy of the trial data? Just a thought.
Harry
|
I agree, Harry . . . lesions (and/or relapses) are probably not a good measure of efficacy. In fact, I don't think # of lesions are even a legitimate measure, are they? Isn't the primary measure a reduction in disease progression (as measured by our EDSS), and secondary, a reduction in relapses?
I think this is just a new way to try to market the efficacy of our meds . . . "More patients are
disease-free with X med". What the he!! is "disease-free" . . . guess that means we are cured, huh?
Lesions, no lesions, inflammation, no inflammation, 3 months of good EDSS results . . .
TIME will tell.
Cherie
__________________
I am not a Neurologist, Physician, Nurse, or Hairdresser ... but I have learned that it is not such a great idea to give oneself a haircut after three margaritas
.